| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.41B | 22.10B | 18.56B | 11.78B | 11.95B | 12.19B |
| Gross Profit | 13.45B | 11.00B | 6.42B | 1.17B | 2.14B | 2.38B |
| EBITDA | 16.70B | 13.12B | 7.87B | 1.86B | 3.28B | 5.54B |
| Net Income | 8.46B | 7.08B | 3.35B | -2.52B | -459.00M | 1.17B |
Balance Sheet | ||||||
| Total Assets | 57.67B | 57.12B | 56.35B | 55.51B | 38.48B | 40.56B |
| Cash, Cash Equivalents and Short-Term Investments | 8.78B | 8.24B | 3.64B | 3.02B | 3.76B | 5.07B |
| Total Debt | 5.53B | 5.71B | 8.97B | 9.44B | 6.13B | 6.30B |
| Total Liabilities | 22.57B | 23.08B | 26.24B | 26.30B | 18.95B | 18.70B |
| Stockholders Equity | 34.93B | 33.87B | 29.93B | 29.03B | 19.35B | 22.02B |
Cash Flow | ||||||
| Free Cash Flow | 12.27B | 7.30B | 2.96B | 97.00M | 1.09B | 2.63B |
| Operating Cash Flow | 12.09B | 10.33B | 6.36B | 2.76B | 3.22B | 4.28B |
| Investing Cash Flow | -434.00M | 739.00M | -2.70B | -1.00B | -2.98B | -1.87B |
| Financing Cash Flow | -7.74B | -7.17B | -2.95B | -1.60B | -2.36B | -2.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $45.80B | 12.69 | 35.18% | 2.82% | ― | ― | |
76 Outperform | $115.65B | 9.00 | 25.22% | 0.95% | 25.14% | 73.19% | |
75 Outperform | $37.80B | 3.80 | 50.82% | 1.51% | 68.87% | 187.55% | |
73 Outperform | $9.97B | 5.53 | 32.51% | 0.87% | 31.10% | 57.19% | |
69 Neutral | $11.79B | 23.91 | 13.65% | 0.07% | 53.03% | 756.69% | |
67 Neutral | $19.38B | 47.71 | 10.92% | 0.77% | 43.24% | 35.16% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |